VTIAX
Price
$32.84
Change
-$0.59 (-1.76%)
Updated
Sep 6 closing price
VTSNX
Price
$131.34
Change
-$2.34 (-1.75%)
Updated
Sep 6 closing price
Ad is loading...

VTIAX vs VTSNX

Header iconVTIAX vs VTSNX Comparison
Open Charts VTIAX vs VTSNXBanner chart's image
Vanguard Total Intl Stock Index Admiral
Price$32.84
Change-$0.59 (-1.76%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$131.34
Change-$2.34 (-1.75%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VTIAX vs VTSNX Comparison Chart
Loading...
VS
VTIAX vs. VTSNX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VTIAX is a StrongSell and VTSNX is a StrongSell.

FUNDAMENTALS
Fundamentals
VTIAX (453B) and VTSNX (453B) have equal amount of cash in the bank . VTSNX (3.29) and VTIAX (3.26) have matching dividends . VTIAX was incepted earlier than VTSNX: VTIAX (14 years) vs VTSNX (14 years). VTIAX (4.00) and VTSNX (4.00) have comparable annual turnover. VTIAX has a lower initial minimum investment than VTSNX: VTIAX (3000) vs VTSNX (5000000). VTSNX (13.75) and VTIAX (13.73) have marching annual gain over last year. VTSNX (25.54) and VTIAX (25.53) have equivalent 5 years return.
VTIAXVTSNXVTIAX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years14 years-
Gain YTD7.7157.705100%
Front LoadN/AN/A-
Min. Initial Investment300050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets453B453B100%
Annual Yield % from dividends3.263.2999%
Returns for 1 year13.7313.75100%
Returns for 3 years-4.58-4.55100%
Returns for 5 years25.5325.54100%
Returns for 10 years28.2426.60106%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORRF34.85-0.11
-0.31%
Orrstown Financial Services
DOW51.31-0.27
-0.52%
Dow
INDI3.84-0.06
-1.41%
indie Semiconductor
GKOS128.35-2.46
-1.88%
Glaukos Corp
XLO0.78-0.04
-4.83%
Xilio Therapeutics